Chemoinformaics analysis of 4-(1-Propenyl)-phenyl-2-methyl butyrate
| Molecular Weight | 218.296 | nRot | 4 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 8 |
| Exact Molecular Weight | 218.131 | nRing | 1 |
| Solubility: LogS | -4.392 | nHRing | 0 |
| Solubility: LogP | 3.562 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 36.9863 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.569 |
| Synth | 2.531 |
| Natural Product Likeliness | 0.474 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.065 |
| Pgp-sub | 0.013 |
| HIA | 0.004 |
| CACO-2 | -4.566 |
| MDCK | 0.0000169 |
| BBB | 0.896 |
| PPB | 0.944505 |
| VDSS | 0.509 |
| FU | 0.0576376 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.856 |
| CYP2c19-inh | 0.908 |
| CYP2c19-sub | 0.501 |
| CYP2c9-inh | 0.694 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.363 |
| CYP2d6-sub | 0.648 |
| CYP3a4-inh | 0.313 |
| CYP3a4-sub | 0.34 |
| CL | 6.3 |
| T12 | 0.216 |
| hERG | 0.038 |
| Ames | 0.038 |
| ROA | 0.038 |
| SkinSen | 0.938 |
| Carcinogencity | 0.436 |
| EI | 0.974 |
| Respiratory | 0.755 |
| NR-Aromatase | 0.032 |
| Antiviral | Yes |
| Prediction | 0.546262 |